Alert from the Swedish Medicines Agency: Many complications with gastric balloons

According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience

Case study by ZEISS Microscopy.

Pilots want to live too

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Hennes tablett ska bli en ny typ av fetmabehandling

Obesitas och diabetes är huvudmålen för en ny tablettbehandling under utveckling av Malmöbolaget Pila Pharma. Företagets mål: att ta upp kampen med de miljardsä...

Inga spår av coronavirus när Londons tunnelbana undersöktes

En nyligen genomförd stickprovsundersökning i Londons tunnelbana visade inga spår av sars-cov-2.

Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”

Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.

Swedish and Danish Life Science – are there still untapped synergies?

not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.

Life Science-podden: The perfect moment for an IPO

When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Ny ordförande för Atlas Antibodies

Åsa Riisberg, styrelseproffs och tidigare partner i EQT, tar över ordförandeklubban i Atlas Antibodies.

Sweden is heavily criticised for not ordering Covid vaccine

Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.

Krönika: Collaboration across borders

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Lundaforskare tilldelas pris från Novo Nordisk Foundation

Hindrik Mulder, professor vid Lunds universitet, får Novo Nordisk Foundation Lecture Prize för sin forskning på diabetes.

CCRM Nordic rekryterar vetenskaplig chef

Anna Falk, professor vid Lunds universitet, blir Chief Scientific Officer på CCRM Nordic.

Accurate removal of prostate tissue

Medical robots play an important role in diagnostics

Blodtest från Roche ska ge tidig Alzheimersdiagnos

Det schweiziska läkemedels- och diagnostikbolaget Roche har tagit fram ett blodtest som ska underlätta diagnostiken inom Alzheimers sjukdom.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.